首页> 外文期刊>BMC Cancer >Survival and prognostic factors in conventional central chondrosarcoma
【24h】

Survival and prognostic factors in conventional central chondrosarcoma

机译:常规中央软骨肉瘤的生存和预后因素

获取原文
           

摘要

Chondrosarcoma is the second most frequent primary malignant bone tumor. Treatment is mainly based on surgery. In general, wide resection is advocated at least in G2 and G3 tumors. But which margins should be achieved? Does localization as for example in the pelvis have a higher impact on survival than surgical margins themselves? From 1982 to 2014, 87 consecutive patients were treated by resection. The margin was defined as R0 (wide resection), R1 (marginal resection) or, R2 if the tumor was left intentionally. All patients were followed for evidence of local recurrence or distant metastasis. Overall and recurrence-free survival were calculated, significance analysis was performed. In 54 (62%) cases a R0 resection, in 31 (36%) a R1 and in 2 (2%) patients a R2-resection was achieved. Histology proved to be G1 in 37 patients (43%), G2 in 41 (47%) and G3 in 9 cases (10%). 5-year local recurrence-free survival (LRFS) was 75%. Local recurrence-free survival showed a significant association with the margin status and the localization of the tumor with pelvic lesions doing worst. Metastatic disease was initially seen in 4 patients (4.6%), 19 others developed metastatic disease during follow-up. Overall survival of the entire group at 5 and 10?years were 79 and 75%, respectively. The quality of surgical margins and the presence of local recurrence did not influence overall survival in a multivariate analysis. Pelvic lesions had a worse prognosis as did higher grades of the tumor, metastatic disease and age. The mainstay of therapy in Chondrosarcoma remains surgery. Risk factors as grading, metastatic disease, age and location significantly influence overall survival. Margin status (R0 vs. R1) did influence local recurrence-free survival but not overall survival. Chondrosarcomas of the pelvis have a higher risk of local recurrence and should be treated more aggressively.
机译:软骨肉瘤是第二常见的原发性恶性骨肿瘤。治疗主要基于手术。通常,至少在G2和G3肿瘤中主张广泛切除。但是应该获得哪些利润?例如在骨盆中的定位比手术边缘本身对生存的影响更大吗?从1982年到2014年,连续87例患者接受了切除术。如果肿瘤是故意留下的,则边缘定义为R0(广泛切除),R1(边缘切除)或R2。对所有患者进行随访,以寻找局部复发或远处转移的证据。计算总生存期和无复发生存期,进行显着性分析。在54例(62%)患者中,R0切除,在31例(36%)中,R1切除,在2例(2%)患者中,进行了R2切除。组织学证明为G1在37例患者中(43%),G2在41例中(47%),G3在9例中(10%)。 5年局部无复发生存率(LRFS)为75%。局部无复发生存率与边缘状态和骨盆病变最严重的肿瘤定位密切相关。最初在4例患者中发现转移性疾病(4.6%),其他19例在随访期间发生了转移性疾病。整个组在5年和10年的总生存率分别为79%和75%。在多变量分析中,手术切缘的质量和局部复发的存在并不影响整体生存。骨盆病变的预后较差,肿瘤分级,转移性疾病和年龄较高。软骨肉瘤的主要治疗手段仍然是手术。危险因素包括分级,转移性疾病,年龄和位置,显着影响整体生存率。保证金状态(R0与R1)确实影响了局部无复发生存率,但没有影响整体生存率。骨盆软骨肉瘤的局部复发风险较高,应更积极地治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号